FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Calabresi

Research Profile

Disorders

Procedures

Anatomy

Concepts & Ideas

Chemicals & Drugs

Living Beings

Young Adult

Physiology

Co-author Network

Publications

TOP 3
Jiwon Oh; Jerry Prince; Peter A Calabresi; Min Chen; Marie Diener-West; Craig K Jones; Scott Douglas Newsome; Shiv Saidha; Seth A Smith; Peter Cm Van Zijl; Kathleen M Zackowski; Daniel Reich
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Jiwon Oh; Shiv Saidha; Yasir Sepah; Elias S Sotirchos; Mohamed Ibrahim; Quan Dong Nguyen; Peter A Calabresi
In vivo demonstration of homonymous hemimacular loss of retinal ganglion cells due to a thalamic lesion using optical coherence tomography.
Arzu Ozturk; Nafi Aygun; BRIAN CAFFO; Peter A Calabresi; Seth A Smith; Daniel Reich
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Calabresi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jiwon Oh; Jerry Prince; Peter A Calabresi; Min Chen; Marie Diener-West; Craig K Jones; Scott Douglas Newsome; Shiv Saidha; Seth A Smith; Peter Cm Van Zijl; Kathleen M Zackowski; Daniel Reich
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(4):427-35.
2013: Jiwon Oh; Shiv Saidha; Yasir Sepah; Elias S Sotirchos; Mohamed Ibrahim; Quan Dong Nguyen; Peter A Calabresi
In vivo demonstration of homonymous hemimacular loss of retinal ganglion cells due to a thalamic lesion using optical coherence tomography.
JAMA neurology 2013;70(3):410-1.
2013: Arzu Ozturk; Nafi Aygun; BRIAN CAFFO; Peter A Calabresi; Seth A Smith; Daniel Reich
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.
Neuroradiology 2013;55(4):431-9.
2013: Jiwon Oh; Jerry L Prince; Daniel Reich; Shiv Saidha; Seth A Smith; Peter C M van Zijl; Min Chen; Marie Diener-West; Craig Jones; Peter A Calabresi
Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.
Neurology 2013;80(6):540-7.
2013: Benjamin M Greenberg; Eva Havrdova; Bernhard Hemmer; Bernd C Kieseier; Robert Lisak; Aaron Miller; Michael K Racke; Lawrence Steinman; Olaf Stuve; Heinz Wiendl; Laura J Balcer; Peter A Calabresi; Bruce A C Cree; Anne Cross; Teresa C Frohman; Ralf Gold; Elliot Frohman
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis.
JAMA neurology 2013;70(2):248-51.
2013: Daniel M Harrison; Scott Douglas Newsome; Dzung L Pham; John Nolan Ratchford; Pierre-Louis Bazin; Peter A Calabresi; Navid Shiee; Daniel Reich
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
Journal of neurology 2013;260(2):397-406.
2013: Stephanie B Syc; Peter A Calabresi; Daniel M Harrison; Shiv Saidha; Michaela Seigo; Daniel Reich
Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.
Multiple sclerosis international 2013;2013():838719.
2013: Lina Hu; Joseph B Margolick; Avindra Nath; TONGGUANG WANG; Katharine A Whartenby; Hao Zhang; Anne R Gocke; Peter A Calabresi
Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes.
PloS one 2013;8(1):e54267.
2013: Shiv Saidha; Michaela A Seigo; Navid Shiee; Elias S Sotirchos; Stephanie B Syc; Laura J Balcer; Ciprian M Crainiceanu; Mary K Durbin; Chistopher Eckstein; Elliot M Frohman; Teresa C Frohman; Scott A Meyer; Scott Douglas Newsome; Jonathan D Oakley; Jiwon Oh; Dzung L Pham; John Nolan Ratchford; Daniel Reich; Peter A Calabresi
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
JAMA neurology 2013;70(1):34-43.
2013: John Nolan Ratchford; Shiv Saidha; Michaela A Seigo; Elias S Sotirchos; Laura J Balcer; Amy Conger; Mary K Durbin; Christopher Eckstein; Elliot M Frohman; Teresa C Frohman; Scott A Meyer; Scott Douglas Newsome; Jonathan D Oakley; Jiwon A Oh; Peter A Calabresi
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Neurology 2013;80(1):47-54.
2013: Elias S Sotirchos; Michaela A Seigo; Peter A Calabresi; Shiv Saidha
Comparison of point estimates and average thicknesses of retinal layers measured using manual optical coherence tomography segmentation for quantification of retinal neurodegeneration in multiple sclerosis.
Current eye research 2013;38(1):224-8.
2012: Paul Blazek; Peter A Calabresi; Amy Conger; Darrel Conger; Scott L Davis; Teresa C Frohman; Ari Green; Benjamin M Greenberg; John Nolan Ratchford; Shiv Saidha; Olaf Stuve; Steven Vernino; Laura J Balcer; Shin Beh; Elliot M Frohman
Objective characterization of the relative afferent pupillary defect in MS.
Journal of the neurological sciences 2012;323(1-2):193-200.
2012: Kristen A Rahn; Rana Rais; Camilo Rojas; Barbara Slusher; M Stathis; Crystal C Watkins; Jesse Alt; Peter B Barker; Jason Brandt; Peter A Calabresi; Ciprian M Crainiceau; Inna Grishkan; Mikhail V Pletnikov; Martin G Pomper; Adam I Kaplin
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(49):20101-6.
2012: Gloria von Geldern; CARLOS PARDO-VILLAMIZAR; Peter A Calabresi; Scott Douglas Newsome
PML-IRIS in a patient treated with brentuximab.
Neurology 2012;79(20):2075-7.
2012: John Nolan Ratchford; Daniel Reich; Kathleen Costello; Peter A Calabresi
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Neurology 2012;79(19):2002-4.
2012: Shiv Saidha; Michaela A Seigo; Yasir J Sepah; Elias S Sotirchos; Laura J Balcer; Ciprian M Crainiceanu; Elliot M Frohman; Jeffrey M Gelfand; Ari J Green; Mohamed A Ibrahim; Scott Douglas Newsome; Quan Dong Nguyen; Jiwon Oh; John Nolan Ratchford; Peter A Calabresi
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Lancet neurology 2012;11(11):963-72.
2012: Ernst-Wilhelm Radue; Krystof Selmaj; Lixin Zhang-Auberson; Catherine Agoropoulou; Pascale Burtin; Peter A Calabresi; Ana de Vera; Gordon Francis; Reinhard Hohlfeld; Frederick Holdbrook; Ludwig Kappos; Nicole Mueller-Lenke; Paul O'Connor; Chris H Polman
Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
Archives of neurology 2012;69(10):1259-69.
2012: Michaela A Seigo; Elias S Sotirchos; Stephanie B Syc; Aleksandra Babiarz; Laura J Balcer; Peter A Calabresi; Christopher Eckstein; E'tona Ford; Elliot M Frohman; Teresa C Frohman; Scott Douglas Newsome; Jonathan D Oakley; John Nolan Ratchford; Shiv Saidha
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques.
Journal of neurology 2012;259(10):2119-30.
2012: Audrey R Frohman; Laura J Balcer; Shin Beh; Peter A Calabresi; Amy Conger; Darrel Conger; Teresa C Frohman; Benjamin Greenberg; Zane Schnurman; Erich Sutter; Elliot M Frohman
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.
Neurology 2012;79(8):797-801.
2012: Katherine M Mullen; Achilles Ntranos; CARLOS PARDO-VILLAMIZAR; Rameeza Allie; Anne R Gocke; Inna V Grishkan; Peter A Calabresi
Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases.
Journal of neuroimmunology 2012;249(1-2):86-92.
2012: Peter A Calabresi; Nicolaas I Bohnen
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?
Neurology 2012;79(6):496-7.
2012: Laura J Balcer; Peter A Calabresi; Eric Eggenberger; Steven L Galetta; Chris H Polman; James V Scanlon; Annie Zhang; Robert Hyde
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Journal of the neurological sciences 2012;318(1-2):119-24.
2012: Christopher Eckstein; E'tona Ford; Gita Byraiah; Peter A Calabresi; Shiv Saidha; Michaela Seigo; Srilakshmi Sharma; Elias S Sotirchos; Aleksandra Stankiewicz; Stephanie B Syc; CARLOS PARDO-VILLAMIZAR
Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography.
Journal of neurology 2012;259(7):1390-8.
2012: Anne R Gocke; Inna V Grishkan; Lina Hu; Lori A Lebson; Hai M Nguyen; Katharine A Whartenby; K George Chandy; Peter A Calabresi
Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(12):5877-86.
2012: Scott D Walter; James A Wilson; Peter A Calabresi; Daniel J Feller; Elliot M Frohman; Kristin M Galetta; Steven L Galetta; Sam B Henderson; Hiroshi Ishikawa; Maureen G Maguire; Reiko E Sakai; Joel Schuman; Laura J Balcer
Ganglion cell loss in relation to visual disability in multiple sclerosis.
Ophthalmology 2012;119(6):1250-7.
2012: Kristin M Galetta; Steven L Galetta; Jennifer Graves; Deacon J Lile; Lauren S Talman; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2012;32(2):116-23.
2012: John Nolan Ratchford; Navid Shiee; Christopher J Endres; Dima A Hammoud; John McGready; Dzung L Pham; Martin G Pomper; Peter A Calabresi
Decreased microglial activation in MS patients treated with glatiramer acetate.
Journal of neurology 2012;259(6):1199-205.
2012: Emily T Wood; Itamar Ronen; Aranee Techawiboonwong; Peter B Barker; Peter A Calabresi; Daniel Harrison; Craig K Jones; Daniel Reich
Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012;32(19):6665-9.
2012: Emmanuelle Waubant; B Weinstock-Guttman; Scott S Zamvil; Amit Bar-Or; Peter A Calabresi; J A Cohen; A Cross; L Ding; A Goodman; D Iklé; N Kachuck; M Kita; H Kopetskie; Michele K Mass; A Miller; Masoud Mokhtarani; S Murphy; Daniel Pelletier; Jana Preiningerova; M Racke; E Rosenberg; S Schwid; C Spencer; Olaf Stüve; Timothy L Vollmer
Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study.
Neurology 2012;78(15):1171-8.
2012: Bernd C Kieseier; Peter A Calabresi
PEGylation of interferon-β-1a: a promising strategy in multiple sclerosis.
CNS drugs 2012;26(3):205-14.
2012: Maureen A Mealy; Scott Douglas Newsome; Dean Wingerchuk; Peter A Calabresi; Benjamin M Greenberg; Michael Levy
Low serum vitamin D levels and recurrent inflammatory spinal cord disease.
Archives of neurology 2012;69(3):352-6.
2012: Jiangyang Zhang; Melina Jones; Michael McMahon; Susumu Mori; Peter A Calabresi
In vivo and ex vivo diffusion tensor imaging of cuprizone-induced demyelination in the mouse corpus callosum.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2012;67(3):750-9.
2012: Stephanie B Syc; Ciprian M Crainiceanu; Mary K Durbin; E'tona Ford; Elliot M Frohman; Michael Levy; Scott A Meyer; Scott Douglas Newsome; Jonathan D Oakley; John Nolan Ratchford; Shiv Saidha; Peter A Calabresi
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.
Brain : a journal of neurology 2012;135(Pt 2):521-33.
2012: Lina Hu; Emily G Baxi; Katharine A Whartenby; Edward Knapp; Jason M Rosenzweig; Hao Zhang; Joseph B Margolick; Inna V Grishkan; Anne R Gocke; Peter A Calabresi
Functional blockade of the voltage-gated potassium channel Kv1.3 mediates reversion of T effector to central memory lymphocytes through SMAD3/p21cip1 signaling.
The Journal of biological chemistry 2012;287(2):1261-8.
2012: TONGGUANG WANG; In Hong Yang; CARLOS PARDO-VILLAMIZAR; Peter A Calabresi; Elliot Choi; Myoung-Hwa Lee; Sung Bin Lee; Avindra Nath
Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel.
PloS one 2012;7(8):e43950.
2012: Yan Jia; Avindra Nath; Scott Douglas Newsome; Tianxia Wu; Bibiana Bielekova; Peter A Calabresi; Linda Chang; Dawn Chen; Gavin Giovannoni; Sharmilee Gnanapavan; Christine A Jelinek; Robert J Cotter
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Clinical proteomics 2012;9(1):9.
2012: Navid Shiee; Kathleen M Zackowski; Pierre-Louis Bazin; BRIAN CAFFO; Peter A Calabresi; Sheena K Farrell; Daniel M Harrison; Scott Douglas Newsome; Dzung L Pham; John Nolan Ratchford; Daniel Reich
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
PloS one 2012;7(5):e37049.
2012: Shiv Saidha; Christopher Eckstein; Peter A Calabresi
New and emerging disease modifying therapies for multiple sclerosis.
Annals of the New York Academy of Sciences 2012;1247():117-37.
2012: Manisha Aggarwal; Susumu Mori; Melina Jones; Peter A Calabresi; Jiangyang Zhang
Probing mouse brain microstructure using oscillating gradient diffusion MRI.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2012;67(1):98-109.
2011: Peter A Calabresi
Inflammation in multiple sclerosis--sorting out the gray matter.
The New England journal of medicine 2011;365(23):2231-3.
2011: Shiv Saidha; Stephanie B Syc; Amy Conger; Mary K Durbin; Christopher Eckstein; Elliot M Frohman; Teresa C Frohman; Scott A Meyer; Scott Douglas Newsome; Jonathan D Oakley; John Nolan Ratchford; Peter A Calabresi
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(12):1449-63.
2011: Ludwig Kappos; David Leppert; David Li; Paul O'Connor; Jeroen Tinbergen; Ming Yin; Frederik Barkhof; Amit Bar-Or; Peter A Calabresi; Robert Glanzman; Stephen L Hauser
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
Lancet 2011;378(9805):1779-87.
2011: Seth A Smith; Peter C M van Zijl; Z R Williams; Peter A Calabresi; Jonathan A D Farrell; S K Farrell; A Gifford; Neil R Miller; Scott Douglas Newsome; John Nolan Ratchford; Daniel Reich
Diffusion tensor imaging of the optic nerve in multiple sclerosis: association with retinal damage and visual disability.
AJNR. American journal of neuroradiology 2011;32(9):1662-8.
2011: Emma C Davies; Elliot M Frohman; Kristin M Galetta; Steven L Galetta; David J Sackel; Lauren S Talman; Peter A Calabresi; Laura J Balcer
Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2011;31(3):260-4.
2011: Lindsay M De Biase; MASAHIRO FUKAYA; Shin H Kang; Masayoshi Mishina; Michele L Pucak; Emily G Baxi; Peter A Calabresi; Dwight E Bergles
NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(35):12650-62.
2011: Stacy L Pineles; David J Sackel; Lauren S Talman; Eileen E Birch; Peter A Calabresi; Elliot M Frohman; Steven L Galetta; Maureen G Maguire; Laura J Balcer
One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis.
American journal of ophthalmology 2011;152(1):133-40.
2011: Scott Douglas Newsome; Joseph I Wang; Jonathan Y Kang; Peter A Calabresi; Kathleen M Zackowski
Quantitative measures detect sensory and motor impairments in multiple sclerosis.
Journal of the neurological sciences 2011;305(1-2):103-11.
2011: Mario Skarica; Katharine A Whartenby; Christopher Eckstein; Peter A Calabresi
Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients.
Journal of neuroimmunology 2011;235(1-2):70-6.
2011: Hormuzdiyar H Dasenbrock; Seth A Smith; Arzu Ozturk; Sheena K Farrell; Peter A Calabresi; Daniel Reich
Diffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disability.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2011;21(2):e41-9.
2011: S B Syc; C V Warner; S Saidha; S K Farrell; A Conger; E R Bisker; J Wilson; Teresa C Frohman; Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis.
Journal of the neurological sciences 2011;302(1-2):19-24.
2011: Shiv Saidha; Stephanie B Syc; Mohamed A Ibrahim; Christopher Eckstein; Christina V Warner; Sheena K Farrell; Jonathan D Oakley; Mary K Durbin; Scott A Meyer; Laura J Balcer; Elliot M Frohman; Jason M Rosenzweig; Scott Douglas Newsome; John Nolan Ratchford; Quan Dong Nguyen; Peter A Calabresi
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
Brain : a journal of neurology 2011;134(Pt 2):518-33.
2011: D M Harrison; BRIAN CAFFO; N Shiee; Jonathan A D Farrell; Pierre-Louis Bazin; S K Farrell; John Nolan Ratchford; Peter A Calabresi; Daniel Reich
Longitudinal changes in diffusion tensor-based quantitative MRI in multiple sclerosis.
Neurology 2011;76(2):179-86.
2011: Christina V Warner; Aleksandra M Stankiewicz; Stephanie B Syc; Laura J Balcer; Esther R Bisker; Peter A Calabresi; Amy Conger; Ciprian M Crainiceanu; Sheena K Farrell; Elliot M Frohman; Teresa C Frohman; Girish Hiremath; Shiv Saidha
The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials.
PloS one 2011;6(8):e22947.
2011: Kristin M Galetta; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2011;8(1):117-32.
2010: Lori Lebson; Anne E. Gocke; Jason Rosenzweig; Jonathan Alder; Curt I Civin; Peter A Calabresi; Katharine A Whartenby
Cutting edge: The transcription factor Kruppel-like factor 4 regulates the differentiation of Th17 cells independently of RORγt.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(12):7161-4.
2010: D Cettomai; G Hiremath; John Nolan Ratchford; Arun Venkatesan; B M Greenberg; John McGready; CARLOS PARDO-VILLAMIZAR; Douglas A Kerr; Elliot M Frohman; Laura J Balcer; justin charles mcarthur; Peter A Calabresi
Associations between retinal nerve fiber layer abnormalities and optic nerve examination.
Neurology 2010;75(15):1318-25.
2010: Cynthia A DeBoy; Horea Rus; Cosmin Tegla; Cornelia Cudrici; Melina Jones; CARLOS PARDO-VILLAMIZAR; Donald Small; Katharine A Whartenby; Peter A Calabresi
FLT-3 expression and function on microglia in multiple sclerosis.
Experimental and molecular pathology 2010;89(2):109-16.
2010: Axel Petzold; Johannes F de Boer; Sven Schippling; Patrik Vermersch; Randy Kardon; Ari Green; Peter A Calabresi; Chris Polman
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.
Lancet neurology 2010;9(9):921-32.
2010: Stephanie B Syc; Christina V Warner; Girish S Hiremath; Sheena K Farrell; John Nolan Ratchford; Amy Conger; Teresa C Frohman; Gary R Cutter; Laura J Balcer; Elliot M Frohman; Peter A Calabresi
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(7):829-39.
2010: Lauren S Talman; Esther R Bisker; David J Sackel; David A Long; Kristin M Galetta; John Nolan Ratchford; Deacon J Lile; Sheena K Farrell; Michael J Loguidice; Gina Remington; Amy Conger; Teresa C Frohman; Dina A Jacobs; Clyde E Markowitz; Gary R Cutter; Gui-Shuang Ying; Yang Dai; Maureen G Maguire; Steven L Galetta; Elliot M Frohman; Peter A Calabresi; Laura J Balcer
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.
Annals of neurology 2010;67(6):749-60.
2010: Peter A Calabresi; Laura J Balcer; Elliot M Frohman
Retinal pathology in multiple sclerosis: insight into the mechanisms of neuronal pathology.
Brain : a journal of neurology 2010;133(Pt 6):1575-7.
2010: Ernst-Wilhelm Radue; William H Stuart; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Richard A Rudick; Fred D Lublin; Bianca Weinstock-Guttman; Daniel R Wynn; Elizabeth Fisher; Athina Papadopoulou; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Journal of the neurological sciences 2010;292(1-2):28-35.
2010: Jonathan A D Farrell; Jiangyang Zhang; Melina Jones; Cynthia A Deboy; Paul N Hoffman; Bennett A Landman; Seth A Smith; Daniel Reich; Peter A Calabresi; Peter C M van Zijl
q-space and conventional diffusion imaging of axon and myelin damage in the rat spinal cord after axotomy.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2010;63(5):1323-35.
2010: TONGGUANG WANG; Myoung-Hwa Lee; Tory Johnson; Rameeza Allie; Lina Hu; Peter A Calabresi; Avindra Nath
Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(14):5020-7.
2010: Amit Bar-Or; Lama Fawaz; Boli Fan; Peter J Darlington; Aja Rieger; Christine Ghorayeb; Peter A Calabresi; Emmanuelle Waubant; Stephen L Hauser; Jiameng Zhang; Craig H Smith
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
Annals of neurology 2010;67(4):452-61.
2010: srikant rangaraju; Keith K Khoo; Zhi-Ping Feng; George Crossley; Daniel Nugent; Ilya Khaytin; Victor Chi; Cory Pham; Peter A Calabresi; Michael Pennington; Raymond S Norton; K George Chandy
Potassium channel modulation by a toxin domain in matrix metalloprotease 23.
The Journal of biological chemistry 2010;285(12):9124-36.
2010: Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Multiple sclerosis: can retinal imaging accurately detect optic neuritis?
Nature reviews. Neurology 2010;6(3):125-6.
2010: Daniel Reich; Arzu Ozturk; Peter A Calabresi; Susumu Mori
Automated vs. conventional tractography in multiple sclerosis: variability and correlation with disability.
NeuroImage 2010;49(4):3047-56.
2010: Ludwig Kappos; Ernst-Wilhelm Radue; Paul O'Connor; Chris Polman; Reinhard Hohlfeld; Peter A Calabresi; Krzysztof Selmaj; Catherine Agoropoulou; Malgorzata Leyk; Lixin Zhang-Auberson; Pascale Burtin
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
The New England journal of medicine 2010;362(5):387-401.
2010: A Ozturk; Seth A Smith; Eliza M Gordon-Lipkin; D M Harrison; N Shiee; Dzung L Pham; BRIAN CAFFO; Peter A Calabresi; Daniel Reich
MRI of the corpus callosum in multiple sclerosis: association with disability.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(2):166-77.
2010: Seth A Smith; Craig K Jones; Aliya Gifford; Visar Belegu; BettyAnn Chodkowski; Jonathan A D Farrell; Bennett A Landman; Daniel Reich; Peter A Calabresi; JOHN MCDONALD; Peter C M van Zijl
Reproducibility of tract-specific magnetization transfer and diffusion tensor imaging in the cervical spinal cord at 3 tesla.
NMR in biomedicine 2010;23(2):207-17.
2010: Bennett A Landman; Jonathan A D Farrell; Seth A Smith; Daniel Reich; Peter A Calabresi; Peter C M van Zijl
Complex geometric models of diffusion and relaxation in healthy and damaged white matter.
NMR in biomedicine 2010;23(2):152-62.
2010: Navid Shiee; Pierre-Louis Bazin; Arzu Ozturk; Daniel Reich; Peter A Calabresi; Dzung L Pham
A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions.
NeuroImage 2010;49(2):1524-35.
2009: Bryn M Burkholder; Benjamin Osborne; Michael J Loguidice; Esther Bisker; Teresa C Frohman; Amy Conger; John Nolan Ratchford; Christina Warner; Clyde E Markowitz; Dina A Jacobs; Steven L Galetta; Gary R Cutter; Maureen G Maguire; Peter A Calabresi; Laura J Balcer; Elliot M Frohman
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
Archives of neurology 2009;66(11):1366-72.
2009: Daniel M Harrison; Peter A Calabresi
Promising treatments of tomorrow for multiple sclerosis.
Annals of Indian Academy of Neurology 2009;12(4):283-90.
2009: Kathleen Hawker; Paul O'Connor; Mark S Freedman; Peter A Calabresi; Jack Antel; Jack Simon; Stephen Hauser; Emmanuelle Waubant; Timothy Vollmer; Hillel Panitch; Jiameng Zhang; Peter Chin; Craig H Smith
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Annals of neurology 2009;66(4):460-71.
2009: Daniel Reich; Seth A Smith; Eliza M Gordon-Lipkin; Arzu Ozturk; BRIAN CAFFO; Laura J Balcer; Peter A Calabresi
Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability.
Archives of neurology 2009;66(8):998-1006.
2009: John Nolan Ratchford; M E Quigg; A Conger; T Frohman; E Frohman; Laura J Balcer; Peter A Calabresi; Douglas A Kerr
Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.
Neurology 2009;73(4):302-8.
2009: Elliot M Frohman; Michael G Dwyer; Teresa C Frohman; Jennifer L Cox; Amber Salter; Benjamin M Greenberg; Sara Hussein; Amy Conger; Peter A Calabresi; Laura J Balcer; Robert Zivadinov
Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
Journal of the neurological sciences 2009;282(1-2):96-105.
2009: Richard A Rudick; A Pace; M R S Rani; R Hyde; M Panzara; S Appachi; J Shrock; S L Maurer; Peter A Calabresi; C Confavreux; S L Galetta; F D Lublin; E-W Radue; Richard M Ransohoff
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
Neurology 2009;72(23):1989-93.
2009: G S Hiremath; D Cettomai; M Baynes; John Nolan Ratchford; Scott Douglas Newsome; D Harrison; Douglas A Kerr; B M Greenberg; Peter A Calabresi
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(6):735-40.
2009: Frederik Barkhof; Peter A Calabresi; David H Miller; Stephen C Reingold
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.
Nature reviews. Neurology 2009;5(5):256-66.
2009: L R Mehta; Steven R Schwid; D L Arnold; Gary R Cutter; S Aradhye; L J Balcer; Peter A Calabresi; J A Cohen; P E Cole; R Glanzman; S Goelz; M Inglese; R Kapoor; L Kappos; R Kreitman; F D Lublin; A Mann; R A Marrie; P O'Looney; C H Polman; Bernard Ravina; S C Reingold; J R Richert; A W Sandrock; E Waubant
Proof of concept studies for tissue-protective agents in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(5):542-6.
2009: Kathleen M Zackowski; Seth A Smith; Daniel Reich; Eliza M Gordon-Lipkin; BettyAnn A Chodkowski; Divya R Sambandan; Michael Shteyman; Amy J Bastian; Peter C M van Zijl; Peter A Calabresi
Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord.
Brain : a journal of neurology 2009;132(Pt 5):1200-9.
2009: Mario Skarica; Tianhong Wang; Erin McCadden; David Kardian; Peter A Calabresi; Donald Small; Katharine A Whartenby
Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(7):4192-9.
2009: A R Salter; A Conger; T C Frohman; Robert Zivadinov; Eric Eggenberger; Peter A Calabresi; Gary R Cutter; Laura J Balcer; E M Frohman
Retinal architecture predicts pupillary reflex metrics in MS.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(4):479-86.
2009: Adam I Kaplin; Katherine A L Carroll; Jenn Cheng; Rameeza Allie; Constantine G Lyketsos; Peter A Calabresi; Paul B Rosenberg
IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's disease.
International psychogeriatrics / IPA 2009;21(2):413-4.
2009: Jiangyang Zhang; Melina Jones; Cynthia A DeBoy; Daniel Reich; Jonathan A D Farrell; Paul N Hoffman; John W Griffin; Kazim A Sheikh; Michael I Miller; Susumu Mori; Peter A Calabresi
Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(10):3160-71.
2009: Michael Hutchinson; Ludwig Kappos; Peter A Calabresi; Christian Confavreux; Gavin Giovannoni; Steven L Galetta; Eva Havrdova; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel Wynn; Frances Lynn; Michael A Panzara
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
Journal of neurology 2009;256(3):405-15.
2009: Jeffrey A Cohen; Peter B Imrey; Peter A Calabresi; K R Edwards; T Eickenhorst; W L Felton; Elizabeth Fisher; Robert J Fox; AD Goodman; C Hara-Cleaver; G J Hutton; B F Mandell; T F Scott; Haosen Zhang; Carolyn Apperson-Hansen; Gerald J Beck; Penny L Houghtaling; Matthew T Karafa; M Stadtler
Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
Neurology 2009;72(6):535-41.
2009: Nicoline Schiess; Peter A Calabresi
Natalizumab: bound to rebound?
Neurology 2009;72(5):392-3.
2009: THIEN NGUYEN; Niraj R Mehta; Katherine Conant; Kee Jun Kim; Melina Jones; Peter A Calabresi; Giorgia Melli; Ahmet Hoke; Ronald Schnaar; Guo-Li Ming; Hongjun Song; Sanjay C Keswani; John W Griffin
Axonal protective effects of the myelin-associated glycoprotein.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(3):630-7.
2008: Elliot M Frohman; James G Fujimoto; Teresa C Frohman; Peter A Calabresi; Gary R Cutter; Laura J Balcer
Optical coherence tomography: a window into the mechanisms of multiple sclerosis.
Nature clinical practice. Neurology 2008;4(12):664-75.
2008: Pablo Villoslada; Jorge Sepulcre; Jon Toledo; Bartolome Bejarano; Peter A Calabresi; E G Lipkin; B-A Chodkowski; Daniel Reich; Seth A Smith; M Pulicken; E Frohman; L Balcer; Gary R Cutter
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
Neurology 2008;71(21):1747; author reply 1747-8.
2008: Katharine A Whartenby; Donald Small; Peter A Calabresi
FLT3 inhibitors for the treatment of autoimmune disease.
Expert opinion on investigational drugs 2008;17(11):1685-92.
2008: David Wheeler; Veera Bandaru; Peter A Calabresi; Avindra Nath; Norman Haughey
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis.
Brain : a journal of neurology 2008;131(Pt 11):3092-102.
2008: Deanna Cettomai; Mathew Pulicken; Eliza Gordon-Lipkin; Amber Salter; Teresa C Frohman; Amy Conger; Xiao Zhang; Gary R Cutter; Laura J Balcer; Elliot M Frohman; Peter A Calabresi
Reproducibility of optical coherence tomography in multiple sclerosis.
Archives of neurology 2008;65(9):1218-22.
2008: Melina Jones; THIEN NGUYEN; C A Deboy; John W Griffin; Katharine A Whartenby; Douglas A Kerr; Peter A Calabresi
Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
Journal of neuroimmunology 2008;199(1-2):83-93.
2008: Chitra Krishnan; Adam I Kaplin; Robert A Brodsky; Daniel B Drachman; Richard J Jones; Dzung L Pham; Nancy D Richert; CARLOS PARDO-VILLAMIZAR; David M Yousem; Edward Hammond; Megan Quigg; Carrilin Trecker; justin charles mcarthur; Avindra Nath; Benjamin M Greenberg; Peter A Calabresi; Douglas A Kerr
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.
Archives of neurology 2008;65(8):1044-51.
2008: Maulik S Zaveri; Amy Conger; Amber Salter; Teresa C Frohman; Steven L Galetta; Clyde E Markowitz; Dina A Jacobs; Gary R Cutter; Gui-Shuang Ying; Maureen G Maguire; Peter A Calabresi; Laura J Balcer; Elliot M Frohman
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
Archives of neurology 2008;65(7):924-8.
2008: Jerome J Graber; S Rameeza Allie; Katherine M Mullen; Melina Jones; TONGGUANG WANG; Chitra Krishnan; Adam I Kaplin; Avindra Nath; Douglas A Kerr; Peter A Calabresi
Interleukin-17 in transverse myelitis and multiple sclerosis.
Journal of neuroimmunology 2008;196(1-2):124-32.
2008: Jonathan A D Farrell; Seth A Smith; Eliza M Gordon-Lipkin; Daniel Reich; Peter A Calabresi; Peter C M van Zijl
High b-value q-space diffusion-weighted MRI of the human cervical spinal cord in vivo: feasibility and application to multiple sclerosis.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2008;59(5):1079-89.
2008: Jeffrey A Cohen; Peter A Calabresi; S Chakraborty; K R Edwards; T Eickenhorst; W L Felton; Elizabeth Fisher; Robert J Fox; AD Goodman; C Hara-Cleaver; G J Hutton; Peter B Imrey; D M Ivancic; B F Mandell; J E Perryman; T F Scott; T T Skaramagas; H Zhang
Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(3):370-82.
2008: Chris H Polman; S C Reingold; Frederik Barkhof; Peter A Calabresi; M Clanet; J A Cohen; Gary R Cutter; M S Freedman; Ludwig Kappos; F D Lublin; Henry McFarland; L M Metz; A E Miller; X Montalban; P W O'Connor; Hillel Panitch; J R Richert; J Petkau; S R Schwid; M P Sormani; A J Thompson; B G Weinshenker; Jerry Wolinsky
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
Neurology 2008;70(13 Pt 2):1134-40.
2008: John Nolan Ratchford; Peter A Calabresi
The diagnosis of MS: white spots and red flags.
Neurology 2008;70(13 Pt 2):1071-2.
2008: Amit Bar-Or; Peter A Calabresi; Douglas Arnold; Douglas Arnlod; Clyde Markowitz; Stuart Shafer; Lloyd H Kasper; Emmanuelle Waubant; Suzanne Gazda; Robert J Fox; Michael Panzara; Neena Sarkar; Sunil Agarwal; Craig H Smith
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
Annals of neurology 2008;63(3):395-400.
2008: Benjamin M Greenberg; Peter A Calabresi
Future research directions in multiple sclerosis therapies.
Seminars in neurology 2008;28(1):121-7.
2008: Daniel Reich; Kathleen M Zackowski; Eliza M Gordon-Lipkin; Seth A Smith; B A Chodkowski; Gary R Cutter; Peter A Calabresi
Corticospinal tract abnormalities are associated with weakness in multiple sclerosis.
AJNR. American journal of neuroradiology 2008;29(2):333-9.
2008: Elliot M Frohman; Fiona Costello; Olaf Stüve; Peter A Calabresi; David H Miller; Simon J Hickman; Robert Sergott; Amy Conger; Amber Salter; Kimberly H Krumwiede; Teresa C Frohman; Laura J Balcer; Robert Zivadinov
Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis.
Archives of neurology 2008;65(1):26-35.
2008: Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; THIEN NGUYEN; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; C Fitzsimmons; Ahmet Hoke; Douglas A Kerr; John W Griffin; Peter A Calabresi; Katherine Conant
Cleavage of myelin associated glycoprotein by matrix metalloproteinases.
Journal of neuroimmunology 2008;193(1-2):140-8.
2008: Kegang Hua; Jiangyang Zhang; Setsu Wakana; Hangyi Jiang; Xin Li; Daniel Reich; Peter A Calabresi; James J Pekar; Peter C M van Zijl; Susumu Mori
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification.
NeuroImage 2008;39(1):336-47.
2007: Tom Li Stephen; Eric D Schwartz; T Lei; Souza Andre; Shipra Mishra; Dina A Jacobs; Clyde E Markowitz; Steven L Galetta; M Ligia Nano-Schiavi; Lisa M Desiderio; Gary R Cutter; Peter A Calabresi; Jayaram K Udupa; Laura J Balcer
Relation of vision to global and regional brain MRI in multiple sclerosis.
Neurology 2007;69(23):2128-35.
2007: Mathew Pulicken; Eliza M Gordon-Lipkin; Laura J Balcer; E Frohman; Gary R Cutter; Peter A Calabresi
Optical coherence tomography and disease subtype in multiple sclerosis.
Neurology 2007;69(22):2085-92.
2007: Daniel Reich; Seth A Smith; Kathleen M Zackowski; Eliza M Gordon-Lipkin; Craig K Jones; Jonathan A D Farrell; Susumu Mori; Peter C M van Zijl; Peter A Calabresi
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis.
NeuroImage 2007;38(2):271-9.
2007: Eliza M Gordon-Lipkin; B Chodkowski; Daniel Reich; Seth A Smith; Mathew Pulicken; Laura J Balcer; E M Frohman; Gary R Cutter; Peter A Calabresi
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
Neurology 2007;69(16):1603-9.
2007: Peter A Calabresi; Gavin Giovannoni; Christian Confavreux; Steven L Galetta; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Fred D Lublin; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.
Neurology 2007;69(14):1391-403.
2007: Lina Hu; Michael Pennington; Qiong Jiang; Katharine A Whartenby; Peter A Calabresi
Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(7):4563-70.
2007: Peter A Calabresi
Investigating glatiramer acetate for relapsing-remitting multiple sclerosis at the double dose--is more better?
Nature clinical practice. Neurology 2007;3(10):540-1.
2007: Richard A Rudick; Deborah Miller; Steve Hass; Michael Hutchinson; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Gavin Giovannoni; Eva Havrdova; Ludwig Kappos; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
Health-related quality of life in multiple sclerosis: effects of natalizumab.
Annals of neurology 2007;62(4):335-46.
2007: Cornelia Cudrici; Takahiro Ito; Ekaterina Zafranskaia; Florin Niculescu; Katherine M Mullen; Sonia Vlaicu; Susan I V Judge; Peter A Calabresi; Horea Rus
Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis.
Experimental and molecular pathology 2007;83(2):198-206.
2007: Cynthia A DeBoy; Jiangyang Zhang; Sonny Dike; Irina Shats; Melina Jones; Daniel Reich; Susumu Mori; THIEN NGUYEN; Brian Rothstein; Robert H Miller; John W Griffin; Douglas A Kerr; Peter A Calabresi
High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord.
Brain : a journal of neurology 2007;130(Pt 8):2199-210.
2007: B M Greenberg; K P Thomas; Chitra Krishnan; Adam I Kaplin; Peter A Calabresi; Douglas A Kerr
Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide.
Neurology 2007;68(19):1614-7.
2007: Melina Jones; Peter A Calabresi
Agar-gelatin for embedding tissues prior to paraffin processing.
BioTechniques 2007;42(5):569-70.
2007: Laura J Balcer; Steven L Galetta; Peter A Calabresi; Christian Confavreux; Gavin Giovannoni; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; David H Miller; Paul W O'Connor; J Theodore Phillips; Chris H Polman; Ernst-Wilhelm Radue; Richard A Rudick; William H Stuart; Andrzej Wajgt; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
Neurology 2007;68(16):1299-304.
2006: Christine Beeton; Heike Wulff; Nathan E Standifer; Philippe Azam; Katherine M Mullen; Michael Pennington; Aaron Kolski-Andreaco; Eric Wei; Alexandra Grino; Debra R Counts; Ping H Wang; Christine J LeeHealey; Brian S Andrews; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Werner W Roeck; Jamshid Tehranzadeh; Kimber L Stanhope; Pavel Zimin; Peter J Havel; Stephen M Griffey; Hans-Günther Knaus; Gerald Nepom; George A Gutman; Peter A Calabresi; K George Chandy
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(46):17414-9.
2006: Daniel Reich; Seth A Smith; Craig K Jones; Kathleen M Zackowski; Peter C M van Zijl; Peter A Calabresi; Susumu Mori
Quantitative characterization of the corticospinal tract at 3T.
AJNR. American journal of neuroradiology 2006;27(10):2168-78.
2006: Seth A Smith; Jonathan A D Farrell; Craig K Jones; Daniel Reich; Peter A Calabresi; Peter C M van Zijl
Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: feasibility and application.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2006;56(4):866-75.
2006: Anita B Venkataramana; CARLOS PARDO-VILLAMIZAR; justin charles mcarthur; Douglas A Kerr; David N Irani; John W Griffin; Peter C Burger; Daniel Reich; Peter A Calabresi; Avindra Nath
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.
Neurology 2006;67(3):383-8.
2006: Patrick B Allen; Venetia Zachariou; Per Svenningsson; A C Lepore; D Centonze; C Costa; S Rossi; G Bender; G Chen; J Feng; G L Snyder; Giorgio Bernardi; Eric J Nestler; Z Yan; Peter A Calabresi; Paul Greengard
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.
Neuroscience 2006;140(3):897-911.
2006: Julie M Johnson-Nauroth; Jerome J Graber; Karen Yao; Steve Jacobson; Peter A Calabresi
Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells.
Journal of neuroimmunology 2006;176(1-2):115-24.
2006: Katherine M Mullen; Monika Rozycka; Horea Rus; Lina Hu; Cornelia Cudrici; Ekaterina Zafranskaia; Michael Pennington; David C Johns; Susan I V Judge; Peter A Calabresi
Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system.
Annals of neurology 2006;60(1):118-27.
2006: Mathew Pulicken; Ayman Koteish; Karen E Debusk; Peter A Calabresi
Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy.
Neurology 2006;66(12):1954-5.
2006: TONGGUANG WANG; Rameeza Allie; Katherine Conant; Norman Haughey; Jadwiga Turchan-Chelowo; Katrin Hahn; Antony Rosen; Joseph P Steiner; Sanjay C Keswani; Melina Jones; Peter A Calabresi; Avindra Nath
Granzyme B mediates neurotoxicity through a G-protein-coupled receptor.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(8):1209-11.
2006: Richard A Rudick; William H Stuart; Peter A Calabresi; Christian Confavreux; Steven L Galetta; Ernst-Wilhelm Radue; Fred D Lublin; Bianca Weinstock-Guttman; Daniel R Wynn; Frances Lynn; Michael A Panzara; Alfred W Sandrock
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
The New England journal of medicine 2006;354(9):911-23.
2006: David N Irani; Caroline Anderson; Rebekah Gundry; Robert J Cotter; Stacy Moore; Douglas A Kerr; justin charles mcarthur; Ned Sacktor; CARLOS PARDO-VILLAMIZAR; Melina Jones; Peter A Calabresi; Avindra Nath
Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis.
Annals of neurology 2006;59(2):237-47.
2006: Jennifer B Fisher; Dina A Jacobs; Clyde E Markowitz; Steven L Galetta; Nicholas J Volpe; M Ligia Nano-Schiavi; Monika L Baier; Elliot M Frohman; Heather Winslow; Teresa C Frohman; Peter A Calabresi; Maureen G Maguire; Gary R Cutter; Laura J Balcer
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
Ophthalmology 2006;113(2):324-32.
2005: Katharine A Whartenby; Peter A Calabresi; Erin McCadden; Bao Nguyen; David Kardian; Tianhong Wang; Claudio Mosse; Drew M Pardoll; Donald Small
Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(46):16741-6.
2005: Adam I Kaplin; Deepa M Deshpande; Erick Scott; Chitra Krishnan; Jessica Carmen; Irina Shats; Tara Martinez; Jennifer Drummond; Sonny Dike; Mikhail V Pletnikov; Sanjay C Keswani; Timothy H Moran; CARLOS PARDO-VILLAMIZAR; Peter A Calabresi; Douglas A Kerr
IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.
The Journal of clinical investigation 2005;115(10):2731-41.
2005: Horea Rus; CARLOS PARDO-VILLAMIZAR; Lina Hu; Erika Darrah; Cornelia Cudrici; Teodora Niculescu; Florin Niculescu; Katherine M Mullen; Rameeza Allie; Liping Guo; Heike Wulff; Christine Beeton; Susan I V Judge; Douglas A Kerr; Hans-Günther Knaus; K George Chandy; Peter A Calabresi
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(31):11094-9.
2005: Rameeza Allie; Lina Hu; Katherine M Mullen; Suhayl Dhib-Jalbut; Peter A Calabresi
Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy.
Archives of neurology 2005;62(6):889-94.
2005: G P A Rice; Hans-Peter Hartung; Peter A Calabresi
Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.
Neurology 2005;64(8):1336-42.
2005: Mathew Pulicken; CN Bash; Kathleen Costello; Areen Said; C Cuffari; J L Wilterdink; Jeffrey M Rogg; P Mills; Peter A Calabresi
Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(2):169-74.
2005: Jerome J Graber; Min Zhan; David Ford; F Kursch; Gordon Francis; Christopher Bever Jr; Hillel Panitch; Peter A Calabresi; Suhayl Dhib-Jalbut
Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis.
Journal of neuroimmunology 2005;161(1-2):169-76.
2005: Christine Beeton; Michael Pennington; Heike Wulff; Satendra Singh; Daniel Nugent; George Crossley; Ilya Khaytin; Peter A Calabresi; Chao Chen; George A Gutman; K George Chandy
Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.
Molecular pharmacology 2005;67(4):1369-81.
2005: Douglas A Kerr; Peter A Calabresi
2004 Pathogenesis of rare neuroimmunologic disorders, Hyatt Regency Inner Harbor, Baltimore, MD, August 19th 2004-August 20th 2004.
Journal of neuroimmunology 2005;159(1-2):3-11.
2004: Peter A Calabresi
Diagnosis and management of multiple sclerosis.
American family physician 2004;70(10):1935-44.
2004: Julia Vennekamp; Heike Wulff; Christine Beeton; Peter A Calabresi; Stephan Grissmer; Wolfram Hänsel; K George Chandy
Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Molecular pharmacology 2004;65(6):1364-74.
2004: Joseph A Frank; Nancy D Richert; CN Bash; L Stone; Peter A Calabresi; B Lewis; R Stone; Thomas Howard; Henry McFarland
Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients.
Neurology 2004;62(5):719-25.
2003: Elliot M Frohman; D S Goodin; Peter A Calabresi; John R Corboy; Patricia K Coyle; M Filippi; J A Frank; Steven L Galetta; R I Grossman; Kathleen Hawker; N J Kachuck; MC Levin; J Theodore Phillips; Michael K Racke; V M Rivera; William H Stuart
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Neurology 2003;61(5):602-11.
2003: Peter A Calabresi; Rameeza Allie; Katherine M Mullen; Sung Hae Yun; Robert W Georgantas; Katharine A Whartenby
Kinetics of CCR7 expression differ between primary activation and effector memory states of T(H)1 and T(H)2 cells.
Journal of neuroimmunology 2003;139(1-2):58-65.
2003: Heike Wulff; Peter A Calabresi; Rameeza Allie; Sung Yun; Michael Pennington; Christine Beeton; K George Chandy
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.
The Journal of clinical investigation 2003;111(11):1703-13.
2002: Peter A Calabresi; H Austin; M K Racke; A Goodman; P Choyke; HW Maloni; Henry McFarland
Impaired renal function in progressive multiple sclerosis.
Neurology 2002;59(11):1799-801.
2002: Subramaniam Sriram; Song-Yi Yao; Charles W Stratton; Peter A Calabresi; William Mitchell; Hideaki Ikejima; Yoshimasa Yamamoto
Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of Patients with clinically definite and monosymptomatic multiple sclerosis.
Clinical and diagnostic laboratory immunology 2002;9(6):1332-7.
2002: M B Panico; C Rizzo; Maria Teresa Desiato; Peter A Calabresi; R Floris; Roberto Massa
Adrenomyeloneuropathy partially responsive to steroid pulse therapy.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2002;23(3):141-2.
2002: Peter A Calabresi; Sung Hae Yun; Rameeza Allie; Katharine A Whartenby
Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFNgamma-producing effector cells.
Journal of neuroimmunology 2002;127(1-2):96-105.
2002: Peter A Calabresi
Considerations in the treatment of relapsing-remitting multiple sclerosis.
Neurology 2002;58(8 Suppl 4):S10-22.
2002: Peter A Calabresi; J L Wilterdink; Jeffrey M Rogg; P Mills; A Webb; Katharine A Whartenby
An open-label trial of combination therapy with interferon beta-1a and oral methotrexate in MS.
Neurology 2002;58(2):314-7.
2001: Peter A Calabresi; Alexandre Prat; Katarzyna Biernacki; J Rollins; Jack P Antel
T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells.
Journal of neuroimmunology 2001;115(1-2):161-7.
1999: Peter A Calabresi; R Martin; S Jacobson
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis.
Journal of neurovirology 1999;5(1):102-8.
1998: Peter A Calabresi; LR Tranquill; Henry McFarland; E P Cowan
Cytokine gene expression in cells derived from CSF of multiple sclerosis patients.
Journal of neuroimmunology 1998;89(1-2):198-205.
1998: Peter A Calabresi; NS Fields; HW Maloni; A Hanham; J Carlino; J Moore; MC Levin; Suhayl Dhib-Jalbut; LR Tranquill; H Austin; Henry McFarland; Michael K Racke
Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.
Neurology 1998;51(1):289-92.
1998: Peter A Calabresi; NS Fields; E C Farnon; Joseph A Frank; CN Bash; T Kawanashi; HW Maloni; Steven Jacobson; Henry McFarland
ELI-spot of Th-1 cytokine secreting PBMC's in multiple sclerosis: correlation with MRI lesions.
Journal of neuroimmunology 1998;85(2):212-9.
1998: F Zipp; Michael Weller; Peter A Calabresi; Joseph A Frank; CN Bash; Johannes Dichgans; Henry McFarland; Roland Martin
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis.
Annals of neurology 1998;43(1):116-20.
1997: M McCutcheon; N Wehner; A Wensky; M Kushner; S Doan; L Hsiao; Peter A Calabresi; T Ha; T V Tran; K M Tate; J Winkelhake; E G Spack
A sensitive ELISPOT assay to detect low-frequency human T lymphocytes.
Journal of immunological methods 1997;210(2):149-66.
1997: Samantha S Soldan; Rossana Berti; N Salem; Paola Secchiero; L Flamand; Peter A Calabresi; Meghan B Brennan; HW Maloni; Henry McFarland; H C Lin; M Patnaik; Steven Jacobson
Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.
Nature medicine 1997;3(12):1394-7.
1997: E Méndez; T Kawanishi; K Clemens; H Siomi; Samantha S Soldan; Peter A Calabresi; J Brady; Steven Jacobson
Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells.
Journal of virology 1997;71(12):9143-9.
1997: Peter A Calabresi; C M Pelfrey; LR Tranquill; HW Maloni; Henry McFarland
VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta.
Neurology 1997;49(4):1111-6.
1997: LA Stone; Joseph A Frank; P S Albert; CN Bash; Peter A Calabresi; HW Maloni; Henry McFarland
Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure.
Neurology 1997;49(3):862-9.
1997: Peter A Calabresi; LR Tranquill; James Dambrosia; LA Stone; HW Maloni; CN Bash; Joseph A Frank; Henry McFarland
Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.
Annals of neurology 1997;41(5):669-74.
1997: Peter A Calabresi; LA Stone; CN Bash; Joseph A Frank; Henry McFarland
Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI.
Neurology 1997;48(5):1446-8.
1996: Henry McFarland; LA Stone; Peter A Calabresi; HW Maloni; CN Bash; Joseph A Frank
MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies.
Multiple sclerosis (Houndmills, Basingstoke, England) 1996;2(4):198-205.
1996: Bernhard Hemmer; Marco Vergelli; Peter A Calabresi; T Huang; Henry McFarland; Roland Martin
Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
Journal of neuroscience research 1996;45(6):852-62.
1995: Katharine A Whartenby; G N Abraham; Peter A Calabresi; Camille N Abboud; P Calabresi; AJ Marrogi; SM Freeman
Gene-modified cells for the treatment of cancer.
Pharmacology & therapeutics 1995;66(1):175-90.
1994: Peter A Calabresi; G Silvestri; S DiMauro; Robert C Griggs
Ekbom's syndrome: lipomas, ataxia, and neuropathy with MERRF.
Muscle & nerve 1994;17(8):943-5.
1994: Peter A Calabresi; James M Powers
An ultrastructural analysis of human post-infectious (allergic) encephalomyelitis.
Acta neuropathologica 1994;87(5):541-4.
1993: Peter A Calabresi; D W Giang; Andrew D Goodman
Progressive spinal multiple sclerosis.
Seminars in neurology 1993;13(4):322-32.
1992: Mauro Silvestrini; Letizia Maria Cupini; Peter A Calabresi; R Floris; Giorgio Bernardi
Migraine with aura-like syndrome due to arteriovenous malformation. The clinical value of transcranial Doppler in early diagnosis.
Cephalalgia : an international journal of headache 1992;12(2):115-9.
1989: R D Rafal; Peter A Calabresi; Cameron Brennan; T K Sciolto
Saccade preparation inhibits reorienting to recently attended locations.
Journal of experimental psychology. Human perception and performance 1989;15(4):673-85.
1989: Paolo Stanzione; Alessandro Stefani; Peter A Calabresi; N B Mercuri; Giorgio Bernardi
Met- and leu-enkephalins inhibit rat cortical neurons intracellularly recorded in vivo while morphine excites them: evidence for naloxone-sensitive and naloxone-insensitive effects.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1989;77(2):302-8.